Cart
sales@molnova.com
BTA-9881
CAS No. 1646857-24-0
BTA-9881( —— )
Catalog No. M34195 CAS No. 1646857-24-0
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 122 | Get Quote |
|
| 5MG | 372 | Get Quote |
|
| 10MG | 635 | Get Quote |
|
| 25MG | 1343 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2403 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBTA-9881
-
NoteResearch use only, not for human use.
-
Brief DescriptionBTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
-
DescriptionBTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorRSV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1646857-24-0
-
Formula Weight390.82
-
Molecular FormulaC21H15ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(N1[C@]2(C=3C(C(=O)N2CC1)=CC=NC3)C4=CC=C(Cl)C=C4)C=5C=CC=NC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
LLL-12
A nonpeptide, cell-permeable STAT3 inhibitor that binds directly to the pTyr705 binding site of the STAT3 monomer.
-
STAT6-IN-2
STAT6-IN-2 (Comp R-84) is a STAT6 inhibitor that effectively reduces the secretion of the chemokine eotaxin-3, which induces eosinophil infiltration. This compound is valuable for studying immune diseases .
-
Indirubin E804
An indirubin derivative that potently blocks constitutive STAT3 signaling in human breast and prostate cancer cells.
